Brian Kral

Research activity per year

Fingerprint

Dive into the research topics where Brian Kral is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

57 Article
3 Review article
2 Letter
1 Chapter
More
- 1 Comment/debate
- 1 Editorial

Assessing the dose of regadenoson required to transiently alter blood-brain barrier integrity in patients with infiltrating gliomas
Grossman, S. A., Romo, C. G., Ye, X., Kral, B., Strowd, R. E., Lesser, G., Raymond, C., Iacoboni, M., Desideri, S., Fisher, J., Danda, N. & Ellingson, B. M., Jan 1 2025, In: Neuro-Oncology Advances. 7, 1, vdaf041.
Research output: Contribution to journal › Article › peer-review

Open Access
A statistical framework for multi-trait rare variant analysis in large-scale whole-genome sequencing studies
NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, Feb 2025, In: Nature Computational Science. 5, 2, p. 125-143 19 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk
Georgakis, M. K., Malik, R., Bounkari, O. E., Hasbani, N. R., Li, J., Huffman, J. E., Shakt, G., Tack, R. W. P., Kimball, T. N., Asare, Y., Morrison, A. C., Tsao, N. L., Judy, R., Mitchell, B. D., Xu, H., Montasser, M. E., Do, R., Kenny, E. E., Loos, R. J. F. & Terry, J. G. & 45 others, Carr, J. J., Bis, J. C., Psaty, B. M., Longstreth, W. T., Young, K. A., Lutz, S. M., Cho, M. H., Broome, J., Khan, A. T., Wang, F. F., Heard-Costa, N., Seshadri, S., Vasan, R. S., Palmer, N. D., Freedman, B. I., Bowden, D. W., Yanek, L. R., Kral, B. G., Becker, L. C., Peyser, P. A., Bielak, L. F., Ammous, F., Carson, A. P., Hall, M. E., Raffield, L. M., Rich, S. S., Post, W. S., Tracy, R. P., Taylor, K. D., Guo, X., Mahaney, M. C., Curran, J. E., Blangero, J., Clarke, S. L., Haessler, J. W., Hu, Y., Assimes, T. L., Kooperberg, C., Bernhagen, J., Anderson, C. D., Damrauer, S. M., Zand, R., Rotter, J. I., de Vries, P. S. & Dichgans, M., Dec 2025, In: Genome Medicine. 17, 1, 27.
Research output: Contribution to journal › Article › peer-review

Open Access
Whole genome sequence analysis of low-density lipoprotein cholesterol across 246 K individuals
NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, Dec 2025, In: Genome biology. 26, 1, 273.
Research output: Contribution to journal › Article › peer-review

Open Access
Association of the Brain White Matter Hyperintensity with the Cognitive Performance in Middle-Aged Population
Hannawi, Y., Yanek, L. R., Kral, B. G., Becker, L. C., Vaidya, D. & Nyquist, P. A., 2024, (Accepted/In press) In: Cerebrovascular Diseases. 542710.
Research output: Contribution to journal › Article › peer-review

Open Access

Brian Kral

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Assessing the dose of regadenoson required to transiently alter blood-brain barrier integrity in patients with infiltrating gliomas

A statistical framework for multi-trait rare variant analysis in large-scale whole-genome sequencing studies

Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk

Whole genome sequence analysis of low-density lipoprotein cholesterol across 246 K individuals

Association of the Brain White Matter Hyperintensity with the Cognitive Performance in Middle-Aged Population

Brian Kral

Fingerprint

Collaborations and top research areas from the last five years

Research output

Assessing the dose of regadenoson required to transiently alter blood-brain barrier integrity in patients with infiltrating gliomas

A statistical framework for multi-trait rare variant analysis in large-scale whole-genome sequencing studies

Rare damaging CCR2 variants are associated with lower lifetime cardiovascular risk

Whole genome sequence analysis of low-density lipoprotein cholesterol across 246 K individuals

Association of the Brain White Matter Hyperintensity with the Cognitive Performance in Middle-Aged Population